Nasal decontamination for the prevention of surgical site infection in Staphylococcus aureus carriers

The Cochrane Database of Systematic Reviews
Zhenmi LiuPeter Wilson

Abstract

Surgical site infection rates in the month following surgery vary from 1% to 5%. Due to the large number of surgical procedures conducted annually, the costs of these surgical site infections (SSIs) can be considerable in financial and social terms. Nasal decontamination using antibiotics or antiseptics is performed to reduce the risk of SSIs by preventing organisms from the nasal cavity being transferred to the skin where a surgical incision will be made. Staphylococcus aureus (S aureus) colonises the nasal cavity and skin of carriers and can cause infection in open or unhealed surgical wounds. S aureus is the leading nosocomial (hospital-acquired) pathogen in hospitals worldwide. The potential effectiveness of nasal decontamination of S aureus is thought to be dependent on both the antibiotic/antiseptic used and the dose of application; however, it is unclear whether nasal decontamination actually reduces postoperative wound infection in S aureus carriers. To assess the effects of nasal decontamination on preventing surgical site infections (SSIs) in people who are S aureus carriers undergoing surgery. In September 2016 we searched the Cochrane Wounds Specialised Register, the Cochrane Central Register of Controlled Trials (C...Continue Reading

References

Apr 29, 1999·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·A J MangramW R Jarvis
Oct 16, 1999·Statistics in Medicine·S G Thompson, S J Sharp
Nov 30, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·S HarbarthD Pittet
Jan 4, 2001·The New England Journal of Medicine·C von EiffG Peters
Feb 24, 2001·Science·U HoffrageG Gigerenzer
Sep 5, 2001·Health Technology Assessment : HTA·J BruceZ H Krukowski
Dec 1, 2001·Trends in Microbiology·S J PeacockF D Lowy
Jun 14, 2002·The New England Journal of Medicine·Trish M PerlUNKNOWN Mupirocin And The Risk Of Staphylococcus Aureus Study Team
Jul 20, 2002·Journal of Infusion Nursing : the Official Publication of the Infusion Nurses Society·John S HibbardAnn R Brady
Jul 30, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·M D KalmeijerJ A J W Kluytmans
Mar 13, 2003·Euro Surveillance : Bulletin Européen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin·R Plowman
Sep 6, 2003·BMJ : British Medical Journal·Julian P T HigginsDouglas G Altman
Jul 29, 2004·Disease-a-month : DM·Candace Thornton SpannJeffrey M Weinberg
Nov 29, 2005·The Lancet Infectious Diseases·Heiman F L WertheimJan L Nouwen
Aug 26, 2006·The Journal of Hospital Infection·A KonvalinkaI W Fong
Jan 5, 2008·The Journal of Antimicrobial Chemotherapy·Miranda M L van RijenJan A J W Kluytmans
Jun 10, 2008·The Journal of Bone and Joint Surgery. British Volume·C EdwardsC G Moran
Jun 14, 2008·The Journal of Hospital Infection·E T M SmythUNKNOWN Hospital Infection Society Prevalence Survey Steering Group
Jul 31, 2008·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Deverick J AndersonKeith S Kaye
Oct 10, 2008·The Cochrane Database of Systematic Reviews·Miranda van RijenJan Kluytmans
Nov 22, 2008·The Journal of Hospital Infection·C D Owens, K Stoessel
Apr 22, 2009·The Journal of Hospital Infection·P AstagneauUNKNOWN ISO-RAISIN Steering Group
Apr 29, 2009·American Journal of Infection Control·Gregory de LissovoyBrian B Vaughn
May 20, 2009·The Journal of Antimicrobial Chemotherapy·T CoatesA Coates
Aug 14, 2009·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Jean B PatelJohn A Jernigan
Jan 8, 2010·The New England Journal of Medicine·Lonneke G M BodeMargreet C Vos
Mar 31, 2010·PLoS Medicine·Kenneth F SchulzUNKNOWN CONSORT Group
Dec 15, 2010·Statistical Methods in Medical Research·Evangelos Kontopantelis, David Reeves
Feb 2, 2011·Mayo Clinic Proceedings·Surbhi LeekhaRandall S Edson
Aug 7, 2012·The Laryngoscope·Andrew G ShumanCarol R Bradford
Apr 11, 2013·Nature Reviews. Neuroscience·Katherine S ButtonMarcus R Munafò

❮ Previous
Next ❯

Citations

Apr 1, 2020·Klinicheskaia laboratornaia diagnostika·E V DetyshevaS A Korovkin
Apr 7, 2020·Anesthesia and Analgesia·Duncan Maguire
Aug 1, 2020·Annals of Clinical Microbiology and Antimicrobials·Jia TangChen Mingquan
Oct 3, 2018·Hernia : the Journal of Hernias and Abdominal Wall Surgery·D J TubreR J Fitzgibbons
Sep 29, 2019·Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete·J LammerT Volz
Jul 22, 2021·Aging Clinical and Experimental Research·Antonio De VincentisUNKNOWN Istituto Superiore Sanità (ISS)

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

The Cochrane Database of Systematic Reviews
Callum Wood, Cheryl Phillips
The Cochrane Database of Systematic Reviews
Jo C DumvilleLucy Land
The Cochrane Database of Systematic Reviews
Jo C DumvilleJane Blazeby
© 2022 Meta ULC. All rights reserved